You know the market. We know how to fund it.
Building digital health or life sciences from Southeastern Europe? That is the entire reason this fund exists. Pre-seed to Series A, usually the first institutional money in, no warm-intro requirement and no specific deck format — one partner reads what you send and answers either way.
Five things we read before the call
{{ activeCriterion }}
{{ activeCriterionBody }}
None of these is a hard gate on its own. If four of the five are there, send the deck — we will tell you what we think about the fifth.
Send us your deckA clear no, early
A fast no is worth more to you than a slow maybe. These four sit outside our mandate however strong the team, so you can spend that time on a fund that does back them.
{{ excludeBody }}
One partner, one decision
You get a partner on the first call, not an associate. Diligence runs with advisors who have built in your market. If it is a no, you will know why — and you will know soon.
Usually first money in
Pre-seed is where we prefer to enter, and we occasionally invest at seed and Series A alongside a co-lead.
No specific pitch format
In any format — a deck, a memo or a Loom — cover vision, business model and growth potential. Ask us for an example if that helps.
Diligence with local operators
Twenty-plus advisors — clinicians, engineers and founders native to the region — pressure-test the market with you rather than at you.
Four steps, no black box
You will always know which step you are on and who is reading. Every deck gets an answer, whichever way it goes — and if the answer is no, you get the reason, because that is the part most funds skip and the only part that is actually useful to you.
You should not have to leave the region to raise the first round.
Teams here reach the same proof point on a fraction of a Western burn. What has been missing is somebody writing the first investment locally and opening the doors that come after it.
What you get besides capital
Our venture partners have built and exited companies worldwide. We match you with the mentors, advisors and board members who shorten the road to product-market fit and to your next round.
Mentors and board members
Matched to your stage and market from a bench of 20+ clinicians, operators and engineers — not whoever happens to be free. If your bottleneck is a regulatory pathway, you get someone who has cleared one; if it is a first hospital contract, someone who has signed one.
Access to Western buyers
Introductions into US and EU hospital systems, payers and pharma through our Manchester, MA base and a large regional diaspora. These are warm conversations with people who have sat on the buying side, not a list of names for you to cold-email.
Grants and non-dilutive funding
Equity is our focus, but the region sits inside a dense layer of EU and national programmes. We help you find the ones that fit, prepare the applications and sequence them so non-dilutive money covers what your round should not have to.
Coaching through the next round
We stay in your corner and work the raise with you: the story, the data room, the metrics that will get questioned, and a target list of co-investors from our own network. We also reserve capital to invest again ourselves — a signal the next round reads.
Send the deck. We answer either way.
No specific format required — cover your vision, business model and growth potential. Ask us for an example deck if that helps.